Enalapril decreases nuclear factor κB activation in the kidney with ureteral obstruction: Rapid Communication

[1]  J. Egido,et al.  Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. , 1997, Circulation.

[2]  G. Nabel,et al.  Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 Coactivator , 1997, Science.

[3]  S. Ricardo,et al.  Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. , 1996, Kidney international.

[4]  E. Prossnitz,et al.  Bradykinin stimulates NF-kappaB activation and interleukin 1beta gene expression in cultured human fibroblasts. , 1996, The Journal of clinical investigation.

[5]  C. Dittrich,et al.  Synergistic Activation of Interleukin-8 Gene Transcription by All-trans-retinoic Acid and Tumor Necrosis Factor-α Involves the Transcription Factor NF-κB* , 1996, The Journal of Biological Chemistry.

[6]  J. Brady,et al.  The Retinoblastoma Gene Product (Rb) Induces Binding of a Conformationally Inactive Nuclear Factor-κB* , 1996, The Journal of Biological Chemistry.

[7]  S. Klahr,et al.  Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. , 1996, Journal of the American Society of Nephrology : JASN.

[8]  S. Lee,et al.  CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Lengyel,et al.  The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities , 1996, Molecular and cellular biology.

[10]  J. Kriegsmann,et al.  Tissue factor expression in an animal model of hydronephrosis. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  P. Libby,et al.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.

[12]  R. Busse,et al.  Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. , 1995, Circulation research.

[13]  C. Alpers,et al.  Cellular events in the evolution of experimental diabetic nephropathy. , 1995, Kidney international.

[14]  H. van Goor,et al.  Myofibroblasts in experimental hydronephrosis. , 1995, The American journal of pathology.

[15]  Jun Ma,et al.  An HMG-like protein that can switch a transcriptional activator to a repressor , 1994, Nature.

[16]  H. Wu,et al.  NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. , 1994, The Journal of biological chemistry.

[17]  S. Klahr,et al.  Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. , 1994, Kidney international.

[18]  S. Klahr,et al.  L-arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis. , 1994, Kidney international.

[19]  H. Brady.  Leukocyte adhesion molecules and kidney diseases. , 1994, Kidney international.

[20]  M. Fujishima,et al.  TGF-beta 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. , 1994, Kidney international.

[21]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[22]  T. Collins.  Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[23]  G. Ding,et al.  Macrophages mediate adverse effects of cholesterol feeding in experimental nephrosis. , 1992, The American journal of physiology.

[24]  P. Sharp,et al.  The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Truong,et al.  Experimental chronic renal ischemia: morphologic and immunologic studies. , 1992, Kidney international.

[26]  G. Nabel,et al.  Cloning of RкB, a novel DNA-binding protein that recognizes the interleukin-2 receptor α chain кB site: New Biol. 3, 1063–1073 , 1992 .

[27]  J. Diamond,et al.  Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: role of macrophages. , 1991, The American journal of physiology.

[28]  S. Klahr,et al.  Effects of probucol on renal function in rats with bilateral ureteral obstruction. , 1990, Kidney international.

[29]  L. Truong,et al.  CHARACTERIZATION OF THE INTERSTITIAL CELLULAR INFILTRATE IN EXPERIMENTAL CHRONIC CYCLOSPORINE NEPHROPATHY , 1990, Transplantation.

[30]  A. Eddy.  Interstitial nephritis induced by protein-overload proteinuria. , 1989, The American journal of pathology.

[31]  S. Klahr,et al.  Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. , 1988, Kidney international.

[32]  A. Michael,et al.  Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis. , 1988, Kidney international.

[33]  J. Lefkowith,et al.  Essential fatty acid deficiency depletes rat glomeruli of resident macrophages and inhibits angiotensin II-induced eicosanoid synthesis. , 1987, The Journal of clinical investigation.

[34]  R. Skidgel,et al.  Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase , 1984, Peptides.

[35]  R. Nagle,et al.  Induction of smooth muscle characteristics in renal interstitial fibroblasts during obstructive nephropathy. , 1973, Laboratory investigation; a journal of technical methods and pathology.